Achieved Net Revenue of $2.3 million, ~42% Growth Over the Prior Year QuarterGross Margins Increased Following Shift in Operational StrategyNet Loss Narrowed to $417,535 ($0.06 per share), a Significant Improvement from the $1.39 million ($0.21 per share) Net Loss in Q2 of 2024Aiming to Attain Profitability in 2025 through Targeted Revenue Growth and Cost-Efficiency MeasuresConference call will be held today, Tuesday, October 29th at 9:00 AM ETCARMEL, Ind., Oct. 29, 2024 /PRNewswire/ -- Syra Health Corp. (N ...